Skip to content
Medical Health Aged Care

Newest Dementia Australia Honorary Medical Advisor promotes dementia-specific tools for GPs

Dementia Australia 3 mins read

Dementia Australia has officially welcomed Dr Marita Long as the newest Dementia Australia Honorary Medical Advisor today.

Dementia Australia CEO Maree McCabe AM said Dr Long, who is a Victorian based GP working across clinical practice, medical education and research, with a strong interest in women’s health and dementia, has made a significant contribution to dementia treatment and care.

“We are honoured to welcome Marita’s medical expertise and passionate advocacy onboard at Dementia Australia,” Ms McCabe said.

Dr Long is a current committee member for the Australian Society of Psychosocial Obstetrics and Gynaecology, a member of the Women in General Practice (Vic) RACGP committee, the Victorian/Tasmanian director on the Board of the Australasian Menopause Society and a co-host of the podcast Dementia in Practice.

Dr Long shared that she is looking forward to commencing her role as Honorary Medical Advisor.

“I am thrilled to join forces with Dementia Australia to raise dementia awareness and provide support for people living with dementia, mild cognitive impairment and the medical practitioners providing care,” Dr Long said.

“It is essential that GPs are better supported and equipped with risk reduction and diagnostic tools to provide informed, personalised support for people of all ages, living with all forms of dementia as well as for people with mild cognitive impairment, their families and carers.”

One resource Dr Long recommends for GPs when treating patients with dementia diagnoses or general cognition concerns is Dementia Australia’s GP referrer pack. The referrer pack includes a dementia service guide, The Dementia Guide, information on the BrainTrack app and a GP referral script pad.

The script pad in particular provides further support, information and resources by directing patients to Dementia Australia for support. GPs fill out a pre-prepared form template and have the options to forward the referral to Helpline@dementia.org.au, suggest their patient directly contact the National Dementia Helpline or alternatively complete an online referral at www.dementia.org.au/referral/script.

“Whether a patient is seeking a clearer understanding of their diagnosis, guidance on adjusting to change, or further education about cognitive impairment, these GP referral scripts can validate their concerns and prompt important conversations with qualified helpline advisors.” Dr Long said.

Order a GP referral pack here: https://www.dementia.org.au/resources/health-professionals/order-your-gp-pack.

Dr Long is presenting at the upcoming HealthEd Seminar, Adelaide Women’s and Children’s Health Update on Saturday, 16 March 2024, and at additional seminars across the country this year. Register to attend a seminar near you via https://www.healthed.com.au/seminars/womens-childrens-health-update/

In her lecture, Dr Long will cover dementia and mild cognitive impairment as a significant health issue. She will discuss the importance of validating and exploring an individual’s concern about cognition, speaking directly to how GPs can provide a more comprehensive cognitive assessment.


Dementia Australia is the source of trusted information, education and services for the estimated more than 400,000 Australians living with dementia, and the more than 1.5 million people involved in their care. We advocate for positive change and support vital research. We are here to support people impacted by dementia, and to enable them to live as well as possible. No matter how you are impacted by dementia or who you are, we are here for you.

For support, please contact the National Dementia Helpline on 1800 100 500. An interpreter service is available. The National Dementia Helpline is funded by the Australian Government. People looking for information can also visit dementia.org.au


-Ends-


Media contacts: Catherine McCarthy, Media and Communications Advisor, 0466 796 201, catherine.mccarthy@dementia.org.au

When talking or writing about dementia please refer to Dementia-Friendly Language Guidelines.

Note to Editors:

We request, where possible, details for the National Dementia Helpline 1800 100 500 appear alongside news stories about dementia, as these stories often prompt questions or concerns:

If this story has prompted any questions or concerns, please call the National Dementia Helpline 1800 100 500 (24 hours, 7 days a week) or visit dementia.org.au.

More from this category

  • Disability, Medical Health Aged Care
  • 20/12/2024
  • 17:36
Kuremara

Kuremara to Open a State-of-the-Art Activity Center in Milton, QLD, in January 2025

Kuremara, a trusted and leading NDIS-registered provider in Australia, is excited to announce the opening of its newest facility—a cutting-edge activity center in Milton,…

  • Contains:
  • Legal, Medical Health Aged Care
  • 20/12/2024
  • 17:29
JGA Saddler

BREAKING NEWS: Australian law firm takes on Johnson & Johnson for selling Australians ineffective medicine

Vision available: Lawyer and doctor VNR, editorial photos and radio grabs included can be found in this SharePoint File In-person lawyer interviews available by…

  • Contains:
  • Medical Health Aged Care
  • 20/12/2024
  • 12:01
NDARC/UNSW

ADHD drug shows promise for treating methamphetamine dependence, landmark Australian study shows

A prescription medication used to treat attention deficit hyperactivity disorder (ADHD) could be repurposed as the first pharmacotherapy for people with methamphetamine dependence, according to a study published in Addiction. Results from the landmark ‘LiMA’ trial show that thepsychostimulant lisdexamfetamine can drastically reduce the need to use methamphetamine among those who are dependent on the illicit drug. Lead author and addiction medicine specialist Professor Nadine Ezard, who is Director of the National Centre for Clinical Research on Emerging Drugs (NCCRED), said the results were promising. "There is currently no pharmacotherapy approved for treating methamphetamine dependence," Professor Ezard said. “While further…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.